XLV - Health Care Select Sector SPDR ETF

NYSEArca - NYSEArca Delayed Price. Currency in USD
91.39
+0.30 (+0.33%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close91.09
Open91.30
Bid88.10 x 1100
Ask94.77 x 1000
Day's Range91.25 - 91.56
52 Week Range78.32 - 91.79
Volume8,144,869
Avg. Volume7,075,492
Net Assets16.98B
NAV88.91
PE Ratio (TTM)N/A
Yield1.41%
YTD Return8.34%
Beta (3y)1.00
Expense Ratio (net)0.14%
Inception Date1998-12-16
Trade prices are not sourced from all markets
  • Investopedia4 days ago

    Investors Get Defensive With Shift to Health Care

    The past week, investors have been moving money into more safe-haven sectors like health care and away from higher-risk categories. Namely, they are shifting funds from technology and financial stocks toward the health care sector, according to Bank of America Merrill Lynch’s monthly fund managers survey.

  • ETF Scorecard: August 17 Edition
    ETF Database4 days ago

    ETF Scorecard: August 17 Edition

    To help investors keep up with the markets, we present our ETF Scorecard. The Scorecard takes a step back and looks at how various asset classes across the globe are performing. The weekly performance is from last Thursday’s open to this week’s Wednesday close.

  • ETF Trends7 days ago

    Healthcare ETFs Can Continue to Impress

    The Health Care Select Sector SPDR (XLV) , the largest healthcare exchange traded fund by assets, is up nearly 3% over the past month and is closing in on record highs. Some market observers are betting healthcare will reach and exceed those all-time highs. XLV allocates about two-thirds of its combined weight to pharmaceuticals and biotechnology stocks.

  • Health Care ETFs Outperforming: Will the Rally Last?
    Zacks8 days ago

    Health Care ETFs Outperforming: Will the Rally Last?

    Health care ETFs are defensive ones, which helped those to shine amid market doldrums.

  • ETF Trends12 days ago

    Investors Flocked to Healthcare ETFs in July

    With the healthcare sector recently outperforming technology, investors have been embracing healthcare exchange traded funds. The Health Care Select Sector SPDR (XLV) is the largest healthcare ETF by assets. XLV allocates about two-thirds of its combined weight to pharmaceuticals and biotechnology stocks.

  • MarketWatch12 days ago

    Health care ETF rises toward 9-day win streak, longest in 3 1/2 years

    The health care sector continues higher, with the SPDR Health Care Select Sector ETF (xlv) on track for the longest win streak in 3 1/2 years, as it holds its lead as the best performing S&P 500 (spx) sector over the past three months. The sector ETF (XLV) edged up 0.1% toward its ninth-straight gain, which would be the longest such streak since the nine-session win streak ended Feb. 23, 2015. The next best sector-ETF performer over that time is the SPDR Consumer Discretionary Select Sector ETF (xly) which is up 9.2%, while the S&P 500 (spx) has gained 6.0% the past three months.

  • ETF Trends13 days ago

    Healthcare ETFs Look to Top Tech

    At the sector level, technology ETFs often receive plenty of attention, but investors should not overlook the recent out-performance offered by healthcare equivalents. For example, over the past 90 days, ...

  • Investopedia14 days ago

    Why Health Care Stocks Are Outshining The Techs

    Health care stocks have made a sharp break to the upside so far in the third quarter, leading the S&P 500 Index (SPX) and outpacing tech stocks in the process. As measured by both the S&P 500 Health Care Index and the Health Care Select Sector SPDR ETF ( XLV), health care stocks closed Monday just 1.8% below their record highs set in January. "Overall they look quite good," said Matt Maley, equity strategist at Miller Tabak, in an interview with  CNBC.

  • Mylan Stock Trending Higher before Its Q2 2018 Results
    Market Realist14 days ago

    Mylan Stock Trending Higher before Its Q2 2018 Results

    On August 3, Mylan (MYL) stock ended the trading day at $38.45 per share, rising ~5.3% compared to the previous day’s closing price. Mylan released its Q1 2018 earnings results on May 9. Mylan is also facing some supply constraints for the EpiPen, its allergy product, due to supply delays from Pfizer (PFE).

  • MarketWatch15 days ago

    Henry Schein's stock rallies after earnings and profit beat, restructuring announced

    MARKET PULSE Shares of Henry Schein Inc. (hsic) rallied 3.5% in premarket trade Monday, after the health care services company beat profit and sales expectations and raised its earnings outlook, while announcing restructuring actions that include job cuts and facility closings.

  • ETF Trends18 days ago

    12 U.S. Sector ETFs to Play in Case of an Escalating Trade War

    If the U.S. is stuck in an escalating trade war, stocks and sector-related ETFs with the highest domestic sales exposure in the U.S. should begin to stand out. “If trade tensions continue to rise and new ...

  • ETF Scorecard: August 3 Edition
    ETF Database18 days ago

    ETF Scorecard: August 3 Edition

    To help investors keep up with the markets, we present our ETF Scorecard. The Scorecard takes a step back and looks at how various asset classes across the globe are performing. The weekly performance is from last Friday’s open to this week’s Thursday close.

  • DaVita’s Q2 2018 Earnings Surpass Analysts’ Estimates
    Market Realist19 days ago

    DaVita’s Q2 2018 Earnings Surpass Analysts’ Estimates

    DaVita (DVA) released its second-quarter earnings after the market closed on August 1. It surpassed Wall Street analysts’ estimates for revenues and EPS and reported non-GAAP EPS of $1.15 on revenues of $2.9 billion. The EPS estimate was $0.97 on revenues of $2.8 billion.

  • Investors: What to Expect from July’s Job Growth Figures
    Market Realist20 days ago

    Investors: What to Expect from July’s Job Growth Figures

    What Will Financial Markets Look for in July's Jobs Report? For the first half of the year, the job growth has averaged 215,000—compared to 182,000 during the same period last year. The job growth in June was broad-based with the private sector adding 202,000 jobs and governments adding 11,000.

  • What to Expect for DaVita’s Q2 2018 Earnings
    Market Realist21 days ago

    What to Expect for DaVita’s Q2 2018 Earnings

    DaVita (DVA), which divides its business into two segments, DaVita Kidney Care and DaVita Medical Group, is set to release its Q2 2018 results tomorrow. Analysts expect it to post EPS of $0.97 on revenue of $2.8 billion. The chart below shows DaVita’s EPS and revenue since Q1 2017, as well as analysts’ Q2 2018 estimates.

  • What to Expect from Incyte’s Q2 2018 Earnings on July 31
    Market Realist22 days ago

    What to Expect from Incyte’s Q2 2018 Earnings on July 31

    Incyte (INCY) is set to release its Q2 2018 earnings on July 31. Wall Street analysts expect EPS at $0.34 on revenues of $473.8 million in Q2 2018.

  • JNJ Stock Rose on Strong Q2 Results: Will Momentum Continue?
    Market Realist27 days ago

    JNJ Stock Rose on Strong Q2 Results: Will Momentum Continue?

    On July 18, 2018, Johnson & Johnson (JNJ) closed at $127.80. The stock fell ~1% from the previous day’s closing price of $129.11. On the previous day, JNJ stock had registered a rise of ~3.5% triggered by the strong Q2 2018 earnings results. The stock is currently trading ~14% lower than its 52-week high of $148.32 reported on January 17, 2018. The stock registered a 52-week low of $118.62 on May 29, 2018, on the news that the company was scrapping a Phase Ib/II trial for Darzalex for the treatment of advanced or metastatic NSCLC (non-small cell lung cancer).

  • MarketWatch28 days ago

    Pfizer to create 450 new jobs in Michigan as it builds a new sterile injectable facility

    Pfizer Inc. (pfe) said Tuesday it will create 450 new jobs, as it unveiled plans to build a new $465 million sterile injectable facility in Portage, Mich. The drugmaker said the new plant is part of its previously announced plan to invest $5 billion in U.S.-based capital projects, as a result of the Tax Cuts and Jobs Act enacted this year. Pfizer currently employs 2,200 people in Portage, about 2.4% of its total workforce of 90,400 employees, according to FactSet. Pfizer's stock rallied 1%.

  • Benzinga28 days ago

    A Scintillating Health Care ETF

    One of the best-performing corners of the health care sector this year is the medical device and equipment space, and total returns confirm the sentiment. The two exchange traded funds dedicated to medical ...

  • How Johnson & Johnson’s Earnings Trended in Q2 2018
    Market Realist29 days ago

    How Johnson & Johnson’s Earnings Trended in Q2 2018

    On July 17, Johnson & Johnson (JNJ) reported its Q2 2018 earnings results. JNJ stock declined ~3.6% on the day. The company registered adjusted EPS (earnings per share) of $2.10, up ~14.8% on a YoY (year-over-year) basis. The adjusted net earnings in the quarter came in at $5.7 billion, a YoY rise of ~14%.

  • Investopedia29 days ago

    Top 3 Healthcare Stocks for 2018

    The healthcare industry is watching the Trump presidency closely. President Trump's promise to repeal and replace Obamacare hit repeated stumbling blocks in Congress. Despite the uncertainty surrounding these efforts to overhaul the nation's healthcare system, a number of healthcare stocks rose dramatically throughout 2017.

  • Investopedialast month

    Top 3 Healthcare ETFs for 2018

    The solid performance of the healthcare market in 2017 has created investment opportunities. These ETFs are poised to take advantage.

  • Top technician says it might be time to make a big change...
    CNBC Videos14 days ago

    Top technician says it might be time to make a big change...

    Technician Carter Worth, Cornerstone Macro, on whether CHURT is the new FANG. With CNBC's Brian Sullivan and the Fast Money traders, Tim Seymour, David Seaburg and Guy Adami.

  • It's time to rotate into value, says JPM's Kolanovic
    CNBC Videos19 days ago

    It's time to rotate into value, says JPM's Kolanovic

    JP Morgan's Marko Kolanovic sees a rotation out of growth and into value. With CNBC's Phil LeBeau and Scott Wapner, and the Fast Money traders, Pete Najarian, Karen Finerman, Steve Grasso and Guy Adami.

  • Health care could challenge tech for market leadership
    CNBC Videos20 days ago

    Health care could challenge tech for market leadership

    CNBC's Mike Santoli breaks down signs that health care could challenge technology for market leadership.